REACTINE Levocabastina 0
Sponsors
LETI Pharma S.L.U., Allergopharma GmbH & Co. KG
Conditions
Allergic rhinoconjunctivitis to Dermatophagoides pteronyssinus and Dermatophagoides farinaeHouse dust mite allergy
Phase 3
A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma
Not yet recruitingCTIS2025-521230-29-00
Target: 320Updated: 2025-12-05
A multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of a subcutaneous allergoid preparation of house dust mite allergens (Dermatophagoides pteronyssinus / Dermatophagoides farinae) in patients with moderate to severe allergic rhinitis/rhinoconjunctivitis with or without controlled allergic asthma.
Not yet recruitingCTIS2026-526213-28-00
Target: 492Updated: 2026-09-30